SOPHiA GENETICS SA (SOPH)
Healthcare
Health Information Services
5.70 $
-1.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns SOPHiA GENETICS SA (SOPH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
48.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.0%
No ownership data is available for this stock yet.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 27. Jul 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | 5.66 | 28,306 |
| 20. Apr 2026 | Jurgi Camblong | CEO | Sell | 4,486 | 5.21 | 23,372 |
| 20. Apr 2026 | Kevin Puylaert | Insider | Sell | 33 | 5.08 | 168 |
| 20. Apr 2026 | Manuela Valente | Insider | Sell | 380 | 5.20 | 1,976 |
| 20. Apr 2026 | Philippe Menu | Insider | Sell | 608 | 5.20 | 3,162 |
| 20. Apr 2026 | Ross Muken | President | Sell | 760 | 5.20 | 3,952 |
| 20. Apr 2026 | Well Daan Van | Insider | Sell | 684 | 5.20 | 3,557 |
| 20. Apr 2026 | Zhenyu Xu | Insider | Sell | 608 | 5.21 | 3,168 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.